TP53 and cancer: It was reported that an aberrant pyruvate metabolism plays a prominent role in cancer, and that cancer cells modulate pyruvate metabolism by the downregulation of p53 and by shifting the expression of glycolytic enzymes, such as pyruvate kinase [31].